TY - JOUR
T1 - Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune Diseases
AU - Bianchi, Matteo
AU - Kozyrev, Sergey V
AU - Notarnicola, Antonella
AU - Sandling, Johanna K
AU - Pettersson, Mats
AU - Leonard, Dag
AU - Sjöwall, Christopher
AU - Gunnarsson, Iva
AU - Rantapää-Dahlqvist, Solbritt
AU - Bengtsson, Anders A
AU - Jönsen, Andreas
AU - Svenungsson, Elisabet
AU - Enocsson, Helena
AU - Kvarnström, Marika
AU - Forsblad-d'Elia, Helena
AU - Magnusson Bucher, Sara
AU - Norheim, Katrine B
AU - Baecklund, Eva
AU - Jonsson, Roland
AU - Hammenfors, Daniel
AU - Eriksson, Per
AU - Mandl, Thomas
AU - Omdal, Roald
AU - Padyukov, Leonid
AU - Andersson, Helena
AU - Molberg, Øyvind
AU - Pyndt Diederichsen, Louise
AU - Syvänen, Ann-Christine
AU - Wahren-Herlenius, Marie
AU - Nordmark, Gunnel
AU - Lundberg, Ingrid E
AU - Rönnblom, Lars
AU - Lindblad-Toh, Kerstin
N1 - This article is protected by copyright. All rights reserved.
PY - 2025/2
Y1 - 2025/2
N2 - OBJECTIVE: Systemic inflammatory autoimmune diseases (SIADs) such as systemic lupus erythematosus (SLE), primary Sjögren disease (pSS), and idiopathic inflammatory myopathies (myositis) are complex conditions characterized by shared circulating autoantibodies and clinical manifestations, including skin rashes, among others. This study was aimed at elucidating the genetics underlying these common features.METHODS: We performed targeted DNA sequencing of coding and regulatory regions from approximately 1,900 immune-related genes in a large cohort of 2,292 well-characterized Scandinavian patients with SIADs with SLE, pSS, and myositis as well as 1,252 controls. A gene-based functionally weighted genetic score for aggregate testing of all genetic variants, including rare variants, was complemented by in silico functional analyses and in vitro reporter experiments.RESULTS: Case-control association analysis detected known and potentially novel genetic loci in agreement with previous genetic and transcriptomics findings linked to the SIAD autoimmune background. Intriguingly, case-case comparisons between patient subgroups with and without specific autoantibodies revealed that the subgroups defined by antinuclear antibodies and anti-double-stranded DNA antibodies have unique genetic profiles reflecting their heterogeneity. When focusing on clinical features, we overall showed that dual-specificity phosphatase 1 (DUSP1) protective genetic variants lead to increased gene expression and potentially to anti-inflammatory effects on the SIAD-associated skin phenotype. This is consistent with recent genetic findings on eczema and with the previously reported down-regulation of the MAPK signaling-related gene DUSP1 in other skin disorders.CONCLUSION: Together, this suggests common molecular mechanisms potentially underlying overlapping clinical manifestations shared among different disorders and informs clinical heterogeneity, which could be translated to improve disease diagnostic and treatment, also in more generalized disease frameworks.
AB - OBJECTIVE: Systemic inflammatory autoimmune diseases (SIADs) such as systemic lupus erythematosus (SLE), primary Sjögren disease (pSS), and idiopathic inflammatory myopathies (myositis) are complex conditions characterized by shared circulating autoantibodies and clinical manifestations, including skin rashes, among others. This study was aimed at elucidating the genetics underlying these common features.METHODS: We performed targeted DNA sequencing of coding and regulatory regions from approximately 1,900 immune-related genes in a large cohort of 2,292 well-characterized Scandinavian patients with SIADs with SLE, pSS, and myositis as well as 1,252 controls. A gene-based functionally weighted genetic score for aggregate testing of all genetic variants, including rare variants, was complemented by in silico functional analyses and in vitro reporter experiments.RESULTS: Case-control association analysis detected known and potentially novel genetic loci in agreement with previous genetic and transcriptomics findings linked to the SIAD autoimmune background. Intriguingly, case-case comparisons between patient subgroups with and without specific autoantibodies revealed that the subgroups defined by antinuclear antibodies and anti-double-stranded DNA antibodies have unique genetic profiles reflecting their heterogeneity. When focusing on clinical features, we overall showed that dual-specificity phosphatase 1 (DUSP1) protective genetic variants lead to increased gene expression and potentially to anti-inflammatory effects on the SIAD-associated skin phenotype. This is consistent with recent genetic findings on eczema and with the previously reported down-regulation of the MAPK signaling-related gene DUSP1 in other skin disorders.CONCLUSION: Together, this suggests common molecular mechanisms potentially underlying overlapping clinical manifestations shared among different disorders and informs clinical heterogeneity, which could be translated to improve disease diagnostic and treatment, also in more generalized disease frameworks.
KW - Adult
KW - Antibodies, Antinuclear/immunology
KW - Autoantibodies/immunology
KW - Autoimmune Diseases/genetics
KW - Case-Control Studies
KW - Female
KW - Humans
KW - Lupus Erythematosus, Systemic/genetics
KW - Male
KW - Middle Aged
KW - Myositis/genetics
KW - Sjogren's Syndrome/genetics
UR - http://www.scopus.com/inward/record.url?scp=85205879351&partnerID=8YFLogxK
U2 - 10.1002/art.42988
DO - 10.1002/art.42988
M3 - Journal article
C2 - 39284741
SN - 2326-5191
VL - 77
SP - 212
EP - 225
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 2
ER -